Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomised, double-blind, cross-over trial
2010110 citationsJournal Articlegreen Open Access
Field-Weighted Citation Impact: 3.68
Medium-dose riboflavin as a prophylactic agent in children with migraine: A preliminary placebo-controlled, randomised, double-blind, cross-over trial | Researchclopedia